Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ)
002437.SZ Stock Price Chart
Explore Harbin Gloria Pharmaceuticals Co., Ltd interactive price chart. Choose custom timeframes to analyze 002437.SZ price movements and trends.
002437.SZ Company Profile
Discover essential business fundamentals and corporate details for Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
27 Oct 2011
Employees
3.09K
Website
https://www.gloria.ccCEO
Leifeng Guo
Description
Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products primarily in the People's Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Harbin, the People's Republic of China.
002437.SZ Financial Timeline
Browse a chronological timeline of Harbin Gloria Pharmaceuticals Co., Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Mar 2025
EPS came in at ¥0.03 , while revenue for the quarter reached ¥551.26M .
Earnings released on 31 Dec 2024
EPS came in at ¥0.02 , while revenue for the quarter reached ¥583.23M .
Earnings released on 29 Sept 2024
EPS came in at ¥0.03 , while revenue for the quarter reached ¥636.20M .
Earnings released on 29 Jun 2024
EPS came in at ¥0.03 , while revenue for the quarter reached ¥618.16M .
Earnings released on 10 May 2024
EPS came in at ¥0.02 , while revenue for the quarter reached ¥586.08M .
Earnings released on 31 Jan 2024
EPS came in at -¥0.05 , while revenue for the quarter reached ¥566.17M .
Earnings released on 29 Jan 2024
EPS came in at ¥0.09 , while revenue for the quarter reached ¥619.35M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.00 , while revenue for the quarter reached ¥751.49M .
Earnings released on 31 Mar 2023
EPS came in at ¥0.01 , while revenue for the quarter reached ¥681.17M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.15 , while revenue for the quarter reached ¥692.89M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.00 , while revenue for the quarter reached ¥815.49M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.01 , while revenue for the quarter reached ¥825.36M .
Earnings released on 29 Apr 2022
EPS came in at -¥0.03 , while revenue for the quarter reached ¥827.11M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.00 , while revenue for the quarter reached ¥774.21M .
Earnings released on 30 Sept 2021
EPS came in at -¥0.00 , while revenue for the quarter reached ¥780.76M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.04 , while revenue for the quarter reached ¥832.21M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.01 , while revenue for the quarter reached ¥705.23M .
Earnings released on 31 Dec 2020
EPS came in at -¥0.12 , while revenue for the quarter reached ¥840.42M .
Earnings released on 30 Sept 2020
EPS came in at -¥0.01 , while revenue for the quarter reached ¥809.50M .
002437.SZ Stock Performance
Access detailed 002437.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.